<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:49:58Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8675515" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8675515</identifier>
        <datestamp>2021-12-20</datestamp>
        <setSpec>ccforum</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Crit Care</journal-id>
              <journal-title-group>
                <journal-title>Critical Care</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1364-8535</issn>
              <issn pub-type="epub">1466-609X</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8675515</article-id>
              <article-id pub-id-type="pmcid">PMC8675515</article-id>
              <article-id pub-id-type="pmc-uid">8675515</article-id>
              <article-id pub-id-type="pmid">34915927</article-id>
              <article-id pub-id-type="publisher-id">3844</article-id>
              <article-id pub-id-type="doi">10.1186/s13054-021-03844-7</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2396-5609</contrib-id>
                  <name>
                    <surname>Mayer</surname>
                    <given-names>Andrew R.</given-names>
                  </name>
                  <address>
                    <email>amayer@mrn.org</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dodd</surname>
                    <given-names>Andrew B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rannou-Latella</surname>
                    <given-names>Julie G.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stephenson</surname>
                    <given-names>David D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dodd</surname>
                    <given-names>Rebecca J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ling</surname>
                    <given-names>Josef M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mehos</surname>
                    <given-names>Carissa J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Robertson-Benta</surname>
                    <given-names>Cidney R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pabbathi Reddy</surname>
                    <given-names>Sharvani</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kinsler</surname>
                    <given-names>Rachel E.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vermillion</surname>
                    <given-names>Meghan S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gigliotti</surname>
                    <given-names>Andrew P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sicard</surname>
                    <given-names>Veronik</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lloyd</surname>
                    <given-names>Amy L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Erhardt</surname>
                    <given-names>Erik B.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gill</surname>
                    <given-names>Jessica M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lai</surname>
                    <given-names>Chen</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Guedes</surname>
                    <given-names>Vivian A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chaudry</surname>
                    <given-names>Irshad H.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.280503.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0409 4614</institution-id><institution>The Mind Research Network/Lovelace Biomedical Research Institute, </institution></institution-wrap>Pete &amp; Nancy Domenici Hall, 1101 Yale Blvd. NE, Albuquerque, NM 87106 USA </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.266832.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 8502</institution-id><institution>Neurology Department, </institution><institution>University of New Mexico School of Medicine, </institution></institution-wrap>Albuquerque, NM 87131 USA </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.266832.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 8502</institution-id><institution>Psychiatry Department, </institution><institution>University of New Mexico School of Medicine, </institution></institution-wrap>Albuquerque, NM 87131 USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.266832.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 8502</institution-id><institution>Psychology Department, </institution><institution>University of New Mexico, </institution></institution-wrap>Albuquerque, NM 87131 USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.266832.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 8502</institution-id><institution>Neurosciences Department, </institution><institution>University of New Mexico School of Medicine, </institution></institution-wrap>Albuquerque, NM 87131 USA </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.420168.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 2738</institution-id><institution>Department of the Army Civilian, </institution><institution>U.S. Army Aeromedical Research Laboratory, </institution></institution-wrap>Fort Rucker, AL 36362-0577 USA </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.420168.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 2160 2738</institution-id><institution>Goldbelt Frontier, Inc., </institution><institution>U.S. Army Aeromedical Research Laboratory, </institution></institution-wrap>Fort Rucker, AL USA </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.266832.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2188 8502</institution-id><institution>Department of Mathematics and Statistics, </institution><institution>University of New Mexico, </institution></institution-wrap>Albuquerque, NM 87131 USA </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.94365.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2297 5165</institution-id><institution>National Institute of Nursing Research, </institution><institution>National Institutes of Health, </institution></institution-wrap>Bethesda, MD 20892 USA </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.265892.2</institution-id><institution-id institution-id-type="ISNI">0000000106344187</institution-id><institution>Department of Surgery, </institution><institution>University of Alabama at Birmingham, </institution></institution-wrap>Birmingham, AL 35294-0019 USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>16</day>
                <month>12</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>16</day>
                <month>12</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>25</volume>
              <elocation-id>428</elocation-id>
              <history>
                <date date-type="received">
                  <day>21</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>11</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">Traumatic brain injury (TBI) and severe blood loss resulting in hemorrhagic shock (HS) represent leading causes of trauma-induced mortality, especially when co-occurring in pre-hospital settings where standard therapies are not readily available. The primary objective of this study was to determine if 17α-ethinyl estradiol-3-sulfate (EE-3-SO<sub>4</sub>) increases survival, promotes more rapid cardiovascular recovery, or confers neuroprotection relative to Placebo following TBI + HS.
</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">All methods were approved by required regulatory agencies prior to study initiation. In this fully randomized, blinded preclinical study, eighty (50% females) sexually mature (190.64 ± 21.04 days old; 28.18 ± 2.72 kg) Yucatan swine were used. Sixty-eight animals received a closed-head, accelerative TBI followed by removal of approximately 40% of circulating blood volume. Animals were then intravenously administered EE-3-SO<sub>4</sub> formulated in the vehicle at 5.0 mg/mL (dosed at 0.2 mL/kg) or Placebo (0.45% sodium chloride solution) via a continuous pump (0.2 mL/kg over 5 min). Twelve swine were included as uninjured Shams to further characterize model pathology and replicate previous findings. All animals were monitored for up to 5 h in the absence of any other life-saving measures (e.g., mechanical ventilation, fluid resuscitation).
</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">A comparison of Placebo-treated relative to Sham animals indicated evidence of acidosis, decreased arterial pressure, increased heart rate, diffuse axonal injury and blood–brain barrier breach. The percentage of animals surviving to 295 min post-injury was significantly higher for the EE-3-SO<sub>4</sub> (28/31; 90.3%) relative to Placebo (24/33; 72.7%) cohort. EE-3-SO<sub>4</sub> also restored pulse pressure more rapidly post-drug administration, but did not confer any benefits in terms of shock index. Primary blood-based measurements of neuroinflammation and blood brain breach were also null, whereas secondary measurements of diffuse axonal injury suggested a more rapid return to baseline for the EE-3-SO<sub>4</sub> group. Survival status was associated with biological sex (female &gt; male), as well as evidence of increased acidosis and neurotrauma independent of EE-3-SO<sub>4</sub> or Placebo administration.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">EE-3-SO<sub>4</sub> is efficacious in promoting survival and more rapidly restoring cardiovascular homeostasis following polytraumatic injuries in pre-hospital environments (rural and military) in the absence of standard therapies. Poly-therapeutic approaches targeting additional mechanisms (increased hemostasis, oxygen-carrying capacity, etc.) should be considered in future studies.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s13054-021-03844-7.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Hypovolemia</kwd>
                <kwd>Brain injuries</kwd>
                <kwd>Traumatic</kwd>
                <kwd>Estrogens</kwd>
                <kwd>Swine</kwd>
                <kwd>Hemodynamics</kwd>
                <kwd>Multiple trauma</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000005</institution-id>
                      <institution>u.s. department of defense</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>W81XWH-17-2-0052</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Mayer</surname>
                      <given-names>Andrew R.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id>
                      <institution>national institute of general medical sciences</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P20GM109089</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par28">Traumatic brain injury (TBI) and severe blood loss resulting in hemorrhagic shock (HS) individually represent leading causes of trauma-induced mortality and are especially detrimental when combined [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Hypothermia, acidosis and coagulopathy represent the hallmark complications of HS, ultimately resulting in oxygen debt at the tissue level [<xref ref-type="bibr" rid="CR4">4</xref>]. Hypovolemia also decreases arterial pressure and increases vasoconstriction, resulting in earlier and more severe cerebral dysautoregulation, reduced blood flow, hypoxia, increased contusion volume and a doubling of mortality rate in concurrent TBI + HS [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Although fluid resuscitation is recommended for HS, unless carefully managed it can also exacerbate brain edema and elevate intracranial pressure [<xref ref-type="bibr" rid="CR7">7</xref>]. Similarly, hyperventilation helps to restore systemic acid–base balance following HS [<xref ref-type="bibr" rid="CR8">8</xref>], whereas respiratory depression is the most common cause of death in preclinical models of moderate-to-severe TBI [<xref ref-type="bibr" rid="CR9">9</xref>]. Respiratory complications are also more common in TBI + HS relative to HS alone in humans [<xref ref-type="bibr" rid="CR10">10</xref>]. Thus, the optimal resuscitation approaches for concurrent TBI + HS remain actively debated [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
              <p id="Par29">Care is further complicated in remote settings (e.g., injuries occurring in the wilderness, developing countries, or military settings) where resuscitative fluids and blood products are not readily available [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Death typically ensues in little more than one hour in the absence of intravenous fluid resuscitation in Class III or IV trauma patients [<xref ref-type="bibr" rid="CR13">13</xref>]. The family of estrogens (17β-estradiol and 17α-ethinyl estradiol-3-sulfate [EE-3-SO<sub>4</sub>]) are naturally occurring steroid hormones that are beneficial in HS [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>] and have been shown to be neuroprotective across multiple neural injury models [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Specifically, EE-3-SO<sub>4</sub> has been shown to increase short-term survival rate (e.g., 3–6 h) in both rodent [<xref ref-type="bibr" rid="CR18">18</xref>] and swine [<xref ref-type="bibr" rid="CR15">15</xref>] models of HS in the absence of typical doses of resuscitation fluids. Proposed mechanisms of action for EE-3-SO<sub>4</sub> include increased cardiac ejection fraction and vasodilation [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR22">22</xref>], increased mitochondrial respiratory complex activity in the myocardium [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], increased cell survival pathways concomitant with decreased cell death pathways, as well as decreased metabolic acidosis and glucose derangement [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. All of the above effects are dependent on estrogen receptor engagement, where specificity was recently confirmed by estrogen receptor antagonists [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
              <p id="Par30">Estrogens freely cross the blood–brain barrier (BBB) and have been demonstrated to maintain and regulate the BBB in both humans and rodents [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. In terms of neuroprotection, seminal work suggests estrogens reduce lesion size and lessen the extent of cell death in the injured brain [<xref ref-type="bibr" rid="CR17">17</xref>], as well as potentially promoting vascular regeneration following injury [<xref ref-type="bibr" rid="CR26">26</xref>]. It has been suggested that the estrogen-mediated maintenance of the BBB may also reduce edema after stroke via dampening of the Na–K–Cl cotransporter mechanism [<xref ref-type="bibr" rid="CR27">27</xref>]. Most pertinent to the current study, EE-3-SO<sub>4</sub> administered one hour following TBI in rodent models resulted in a reduction in intracranial pressure, edema and neuroinflammation while increasing cerebral perfusion pressure and partial pressure of oxygen in brain tissue [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>], but did not affect markers of diffuse axonal injury [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
              <p id="Par31">Due to similar homology in terms of hemostatic mechanisms, cardiovascular systems and brain structure (gyrencephalic, similar gray-white matter ratios), swine represent the most commonly utilized species for large animal models of TBI + HS [<xref ref-type="bibr" rid="CR3">3</xref>]. The majority of these studies have primarily utilized controlled cortical impact or fluid percussion injury, even though closed-head, acceleration injuries represent the most common form of human TBI [<xref ref-type="bibr" rid="CR31">31</xref>]. A recent study reported acute mortality rates of approximately 88% and 13%, respectively, in an acceleration model of TBI with either 55% or 40% blood loss in the absence of any treatment relative to Shams [<xref ref-type="bibr" rid="CR32">32</xref>]. In addition to traditional metrics of metabolic derangement associated with HS, results from this study also validated the sensitivity of several blood-based biomarkers for measuring diffuse axonal injury, blood–brain barrier breach and neuroinflammation in swine (glial fibrillary acidic protein [GFAP], neurofilament light chain [NFL], ubiquitin C-terminal hydrolase [UCH-L1], amyloid-beta 40 [Aβ40] and 42 [Aβ42]) that are commonly used in clinical settings [<xref ref-type="bibr" rid="CR33">33</xref>]. To our knowledge, there have been no studies examining the efficacy of EE-3-SO<sub>4</sub> in a large animal model of TBI + HS.</p>
              <p id="Par32">The current study therefore had two primary aims. The first was to attempt to replicate previous findings of metabolic derangement and neurotrauma in a swine model of closed-head, accelerative TBI + HS (i.e., Placebo-treated animals relative to uninjured Shams). The second aim examined the efficacy of EE-3-SO<sub>4</sub> to prolong survival in a pre-hospital environment that mimicked more austere levels of care (absence of resuscitative fluids or mechanical ventilation; [<xref ref-type="bibr" rid="CR32">32</xref>]). Based on previous literature [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], we postulated that EE-3-SO<sub>4</sub> would increase survival time and improve hemodynamic functioning, while subsequently decreasing markers of metabolic acidosis, BBB breach and neuroinflammation. Second, we also predicted that there would be a statistically null effect for blood-based and immunohistochemical markers of diffuse axonal injury [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Animal preparation</title>
                <p id="Par33">The methods used in the current study are nearly identical to a previous publication [<xref ref-type="bibr" rid="CR32">32</xref>] and are therefore only briefly presented here. All animal procedures (see Table <xref rid="Tab1" ref-type="table">1</xref>) were approved by the local Institutional Animal Care and Use Committee (Lovelace Biomedical, FY17-077, FY20-133) and the US Army Medical Research &amp; Development Command Office of Research Protections Animal Care and Use Review Office (DM160115, DM160115.e001) prior to study initiation. The study was conducted in accordance with Animal Research: Reporting In Vivo Experiments 2.0 guidelines [<xref ref-type="bibr" rid="CR34">34</xref>]. Specifically, eighty sexually mature Yucatan swine (28.18 ± 2.72 kg; 40 females and 40 males; 190.64 ± 21.04 days old at the time of experimental procedures) were obtained from Premier Biosource (formerly S&amp;S Farms, Ramona, California, USA). Animals were screened and vaccinated for common swine diseases by the vendor prior to arrival at the research facility. Upon arrival, animals were examined by a veterinarian and underwent a quarantine (i.e., no experimental procedures) and acclimation period of 7 days, with observation daily prior to the start of experimental procedures. Animals were single-sex group-housed when possible (exceptions made for odd number of animals per sex or behavioral incompatibility) in indoor runs on a 12:12 light/dark cycle. Environmental conditions were maintained between ~ 16–27 °C and ~ 30–70% relative humidity. Animals were limit fed (based on age and weight) twice per day and had ad libitum access to water. Animals were randomly assigned in a blocked fashion to the experimental drug (EE-3-SO<sub>4</sub> vs. Placebo) and the actual/mock rough ground transport conditions, or to the uninjured Sham cohort. The blocked assignment controlled for biological sex and experimental arm to alleviate concerns about potential time-related effects. All in-life procedures with the exception of rough ground transport, data quality assurance and data scoring were conducted in a blinded fashion, with blind broken immediately prior to conducting the final analyses. Rough ground transport did not significantly affect survival rates (<italic>p</italic> &gt; 0.10) and therefore will be presented in a separate manuscript.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Timeline of critical experimental procedures</p></caption><graphic position="anchor" xlink:href="13054_2021_3844_Tab1_HTML" id="MO111"/></table-wrap></p>
                <p id="Par34">During experimental procedures, animals were maintained under general anesthesia using a combination of isoflurane, midazolam and ketamine (see Additional file <xref rid="MOESM1" ref-type="media">1</xref> for dosing). Femoral arteries were catheterized and flushed every 20 min in conjunction with a single artificial breath. Blood samples were obtained and analyzed using point-of-care devices for primary (glucose, lactate and bicarbonate [HCO<sub>3</sub>]) and secondary (potential hydrogen [pH], partial CO<sub>2</sub> pressure [PCO<sub>2</sub>], sodium [Na], potassium [K], ionized calcium [iCa]) variables. A Simoa HD-1 Analyzer was used to determine concentrations of NFL, UCH-L1 and GFAP (primary outcome measures), as well as Aβ40 and Aβ42 (secondary outcome measures). Invasive arterial pressure monitoring was used to calculate primary (shock index [SI]; pulse pressure [PP]) and secondary (mean arterial pressure [MAP] and heart rate) hemodynamic variables in 30-s epochs. Focused analyses examined the effects of EE-3-SO<sub>4</sub> on hemodynamics at 5 min and 20 min immediately post-administration.</p>
                <p id="Par35">A closed-head TBI was initiated via a pneumatic device targeting a rotation of 250 radians/second in the coronal plane [<xref ref-type="bibr" rid="CR32">32</xref>] with a subset of animals monitored for actual head kinematics [<xref ref-type="bibr" rid="CR35">35</xref>]. Animals were immediately placed in lateral recumbency and subjected to arterial hemorrhage via controlled removal of approximately 40% of estimated total blood volume 161 ± 48.7 s after the TBI. Animals were then administered EE-3-SO<sub>4</sub> (formulated in the vehicle at 5.0 mg/mL and dosed at 0.2 mL/kg) or Placebo (0.45% sodium chloride solution) as an intravenous administration over 5 min via a continuous pump (0.2 mL/kg) and monitored.</p>
                <p id="Par36">Single immunohistochemistry labeling was performed to examine for extravasated serum proteins (Immunoglobulin G; IgG) as markers of blood–brain barrier integrity, axonal pathology (amyloid precursor protein; APP), and upregulation of microglia (ionized calcium-binding adaptor molecule 1; IBA1).</p>
              </sec>
              <sec id="Sec4">
                <title>Statistical plan</title>
                <p id="Par37">The first series of analyses attempted to replicate previous observations [<xref ref-type="bibr" rid="CR32">32</xref>] of blood-based biomarker findings of metabolic derangement and neurotrauma in a swine model of closed-head, accelerative TBI + HS (i.e., Placebo vs. Sham). All terminal samples from non-surviving animals were excluded from analyses due to extreme physiological derangement (e.g., 5 min of apnea) and non-standard data collection times. Generalized linear models (GLM) with appropriate (Gaussian or Gamma) response distributions determined by the model fit or linear mixed-effects (LME) models were utilized for analyses (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>). Similar to a previous publication [<xref ref-type="bibr" rid="CR32">32</xref>], baseline measurements were used as a covariate for all analyses when available.</p>
                <p id="Par38">The second series of analyses examined the efficacy of EE-3-SO<sub>4</sub> in promoting survival and improving physiological endpoints (i.e., EE-3-SO<sub>4</sub> vs. Placebo). Any animal that did not survive at least 20 min post-blood loss was excluded from drug-focused analyses. Survival rates between the cohorts were assessed using a Cox proportional-hazards model test. Similar tests (GLM, LME) and methodologies (e.g., baseline as a covariate, terminal samples excluded) were used to investigate differences in physiological markers between EE-3-SO<sub>4</sub> and Placebo-treated animals. Any data that were collected with minor variations in protocol were individually reviewed for outlier status (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>), with all analyses conducted with and without extreme outliers (results unchanged).</p>
                <p id="Par39">Finally, a series of LME models were fit to determine variables that differed between non-surviving and surviving animals independent of drug assignment. Specifically, surviving animals (<italic>N</italic> = 16) were matched to non-surviving animals (<italic>N</italic> = 16) based on biological sex, drug assignment and temporal cohort (whenever was possible). The two groups were compared across all primary and secondary variables based on the last successfully acquired timepoint prior to death (timepoint also matched to surviving animals), with matched data eliminated for blood-based biomarkers in the event of death occurring prior to acquisition. Both baseline measurements and acquisition time were entered as additional covariates into the model. The latter controlled for the fact that the temporal course of each biomarker was expected to fluctuate as a function of time post-injury [<xref ref-type="bibr" rid="CR32">32</xref>]. Due to the exploratory nature of these analyses, individual tests were not corrected for multiple comparisons.</p>
              </sec>
            </sec>
            <sec id="Sec5">
              <title>Results</title>
              <sec id="Sec6">
                <title>Characterization of model pathology</title>
                <p id="Par40">No significant (all <italic>p</italic>’s &gt; 0.05) group differences existed at baseline for hemodynamic, point-of-care, or neural biomarkers between Placebo (<italic>N</italic> = 34) and uninjured Sham (<italic>N</italic> = 12) cohorts. Significant Group × Time interactions were observed for glucose (<italic>F</italic><sub>4,35.93</sub> = 25.45, <italic>p</italic> &lt; 0.001), lactate (<italic>F</italic><sub>4,22.21</sub> = 6.32, <italic>p</italic> = 0.001) and HCO<sub>3</sub> (<italic>F</italic><sub>4,23.87</sub> = 7.03, <italic>p</italic> = 0.001) following Bonferroni correction (0.05/3 = 0.017; see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A). Follow-up tests indicated reduced HCO<sub>3</sub> (all <italic>p</italic>’s &lt; 0.001; Cohen’s <italic>d</italic> =  − 3.40 to − 1.68), increased glucose (all <italic>p</italic>’s &lt; 0.001; <italic>d</italic> = 1.38 to 3.91) and increased lactate (all <italic>p</italic>’s &lt; 0.001; <italic>d</italic> = 1.79 to 2.94) in the Placebo cohort, which all demonstrated evidence of an incomplete recovery trajectory at 295 min post-TBI. Secondary point-of-care (Bonferroni correction at 0.05/5 = 0.01) variables also demonstrated significant Group × Time interactions for Na (<italic>p</italic> &lt; 0.001) and K (<italic>p</italic> &lt; 0.001). Main effects of Group were observed for pH (<italic>p</italic> = 0.002), PCO<sub>2</sub> (<italic>p</italic> = 0.004) and iCa (<italic>p</italic> &lt; 0.001), with Time effects presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.
</p>
                <p id="Par41">Significant Group × Time interactions were also observed for the primary hemodynamic variables of PP (<italic>F</italic><sub>4,34.02</sub> = 41.50, <italic>p</italic> &lt; 0.001) and SI (<italic>F</italic><sub>4,22.18</sub> = 10.72, <italic>p</italic> &lt; 0.001) following Bonferroni correction (0.05/2 = 0.025). SI was significantly decreased post-TBI for the Placebo relative to Sham cohort (<italic>p</italic> = 0.002, <italic>d</italic> =  − 1.04), but then increased after blood loss with evidence of an incomplete recovery (all <italic>p</italic>’s ≤ 0.001; <italic>d</italic> = 1.56 to 1.89). In contrast, PP was significantly (<italic>p</italic>’s ≤ 0.003; <italic>d</italic> =  − 5.88 to − 1.11) reduced in Placebo animals immediately post-blood loss until 85 min post-TBI, with statistical evidence of full recovery at 145 min post-TBI (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1B). Significant Group × Time interactions (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>) were also observed for secondary hemodynamic measurements of HR (<italic>p</italic> &lt; 0.001) and MAP (<italic>p</italic> &lt; 0.001).</p>
                <p id="Par42">Immunohistochemical results indicated significant increases in cortical APP (Wald-<italic>χ</italic><sup>2</sup> = 47.22, <italic>p</italic> &lt; 0.001, <italic>d</italic> = 3.11), as well as cortical (Wald-<italic>χ</italic><sup>2</sup> = 7.01, <italic>p</italic> = 0.008, <italic>d</italic> = 1.14) and cerebellar (Wald-<italic>χ</italic><sup>2</sup> = 20.45, <italic>p</italic> &lt; 0.001, <italic>d</italic> = 1.82) IgG following multiple comparison corrections (Bonferroni 0.05/4 = 0.013). Conversely, cortical IBA1 did not meet corrected significance (<italic>p</italic> = 0.082, <italic>d</italic> = 0.60), and this marker was excluded from further analyses. From a qualitative perspective, 24/34 animals in the Placebo cohort exhibited findings of intracranial bleeding on gross necropsy examination. This was most typically characterized by hemorrhage along the dorsal and ventral surfaces of the cerebellum, as well as the dorsal surface of the cortex in 7 animals. No Sham animals exhibited intracranial bleeding on gross necropsy examination.</p>
                <p id="Par43">For blood-based biomarkers (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1C), significant Group × Time interactions were also observed for primary measures of NFL (<italic>F</italic><sub>1,32.00</sub> = 56.83, <italic>p</italic> &lt; 0.001) and GFAP (<italic>F</italic><sub>1,32.85</sub> = 29.25, <italic>p</italic> &lt; 0.001), with a main effect of Group (Placebo &gt; Sham; <italic>F</italic><sub>1,34.30</sub> = 12.40, <italic>p</italic> = 0.001, <italic>d</italic> = 1.18) for UCH-L1 (Bonferroni correction 0.05/3 = 0.017). GFAP was significantly elevated across time points (both <italic>p</italic>’s &lt; 0.001; <italic>d</italic> = 2.96 to 3.31) in the Placebo relative to Sham cohort, with a larger magnitude of difference at the terminal sample. In contrast, NFL was only significantly elevated in Placebo relative to Sham animals at the terminal sample (<italic>p</italic> &lt; 0.001, <italic>d</italic> = 2.66). Secondary measures (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>) of Aβ42 (<italic>p</italic> = 0.011) exhibited a significant Group × Time interaction while Aβ40 demonstrated an overall main effect of Group (<italic>p</italic> &lt; 0.001; Placebo &gt; Shams).</p>
              </sec>
              <sec id="Sec7">
                <title>Analyses testing efficacy of EE-3-SO<sub>4</sub></title>
                <p id="Par44">A total of four animals expired either during the blood loss procedures (1 EE-3-SO<sub>4</sub>) or within 20 min of blood loss (2 EE-3-SO<sub>4</sub>; 1 Placebo) and were excluded from analyses based on a priori criteria. There were no statistical differences between remaining EE-3-SO<sub>4</sub> (<italic>N</italic> = 31) and Placebo (<italic>N</italic> = 33) cohorts on age, body weight or anesthetic time for catheter placement (all <italic>p</italic>’s &gt; 0.05). Comparison of HYGE parameters (Table <xref rid="Tab2" ref-type="table">2</xref>) indicated no significant cohort effects for peak angular velocity, time-to-peak and deceleration time (all <italic>p</italic>’s &gt; 0.05). Similarly, there were no significant differences between the groups in terms of total blood volume removed with the pump, or the amount of time that elapsed between the TBI and the onset of the blood loss procedure (all <italic>p</italic>’s &gt; 0.05). Baseline ionized calcium (iCa) was significantly increased (uncorrected Wald-<italic>χ</italic><sup>2</sup> = 4.31, <italic>p</italic> = 0.038) for the EE-3-SO<sub>4</sub> (1.41 ± 0.01 mmol/L) relative to Placebo (1.38 ± 0.01 mmol/L) cohort. Otherwise, there were no other significant group differences for all hemodynamic, point-of-care and neural biomarkers between EE-3-SO<sub>4</sub> and Placebo groups at baseline (all <italic>p</italic>’s &gt; 0.05; <italic>d</italic> = 0.00 to 0.52).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Animal characteristics and HYGE parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Placebo (<italic>N</italic> = 33)</th><th align="left">EE-3-SO<sub>4</sub> (<italic>N</italic> = 31)</th><th align="left"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" colspan="4">Measure</td></tr><tr><td align="left"> Weight (kg)</td><td char="±" align="char">28.07 ± 3.22</td><td char="±" align="char">28.12 ± 2.62</td><td char="." align="char">0.952</td></tr><tr><td align="left"> Age (days)</td><td char="±" align="char">190.64 ± 22.57</td><td char="±" align="char">186.65 ± 18.72</td><td char="." align="char">0.433</td></tr><tr><td align="left"> reTBV(%)</td><td char="±" align="char">40.2 ± 1.4</td><td char="±" align="char">40.2 ± 1.5</td><td char="." align="char">0.970</td></tr><tr><td align="left" colspan="4">HYGE</td></tr><tr><td align="left"> Peak velocity (rad/s)</td><td char="±" align="char">249.25 ± 6.25</td><td char="±" align="char">248.80 ± 6.35</td><td char="." align="char">0.777</td></tr><tr><td align="left"> Decel time (ms)</td><td char="±" align="char">4.07 ± 4.04</td><td char="±" align="char">3.61 ± 3.89</td><td char="." align="char">0.651</td></tr><tr><td align="left"> Time to peak (ms)</td><td char="±" align="char">6.15 ± 0.24</td><td char="±" align="char">6.15 ± 0.22</td><td char="." align="char">0.932</td></tr></tbody></table><table-wrap-foot><p><italic>Decel time</italic> deceleration time, <italic>ms</italic> millisecond, <italic>rad/s</italic> radians per second, <italic>reTBV</italic> removed estimated total blood volume</p></table-wrap-foot></table-wrap></p>
                <p id="Par45">The Cox proportional-hazards model indicated that the percentage of animals surviving to 295 min post-TBI (i.e., duration of the experiment; Fig. <xref rid="Fig1" ref-type="fig">1</xref>) was significantly higher (<italic>β</italic> =  − 1.14, <italic>Z</italic> =  − 1.70, <italic>p</italic><sub>one-sided</sub> = 0.044) for the EE-3-SO<sub>4</sub> cohort (28/31; 90.3%) relative to Placebo cohort (24/33; 72.7%). Specifically, there were five deaths in the Placebo cohort relative to 1 death in the EE-3-SO<sub>4</sub> cohort by 145 min following TBI, with an additional 4 deaths in the Placebo cohort and 2 deaths in the EE-3-SO<sub>4</sub> cohort between 145 and 295 min. The majority of animals in both the Placebo (7/9) and EE-3-SO<sub>4</sub> (3/3) groups expired as a result of respiratory arrest rather than cardiac arrest.<fig id="Fig1"><label>Fig. 1</label><caption><p>This figure depicts significantly increased survival rate and time (minutes post-traumatic brain injury [TBI]) for the EE-3-SO<sub>4</sub> (solid line) relative to Placebo (dashed line) cohort based on a one-sided Cox proportional-hazards model (Cox PH). The end of the experiment occurred at 295 min post-TBI</p></caption><graphic xlink:href="13054_2021_3844_Fig1_HTML" id="MO1"/></fig></p>
                <p id="Par46">Results from primary point-of-care measurements of glucose, lactate and bicarbonate (Group × Time: see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1 and Fig. <xref rid="Fig2" ref-type="fig">2</xref>A) were null after Bonferroni correction (0.05/3 tests; all <italic>p</italic>’s &gt; 0.017, <italic>d</italic> =  − 0.12 to 0.16), as were secondary point-of-care variables (all <italic>p</italic>’s &gt; 0.01, <italic>d</italic> =  − 0.14 to 0.23; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2). Results indicated that there were no significant main effects or interactions (Group × Time: see Fig. <xref rid="Fig2" ref-type="fig">2</xref>B) between EE-3-SO<sub>4</sub> and Placebo cohorts on SI or PP following Bonferroni correction (0.05/2 tests; all <italic>p</italic>’s &gt; 0.025, <italic>d</italic> =  − 0.46 to − 0.15). Secondary variables of MAP and heart rate were null for all main effects and interactions as well (<italic>d</italic> =  − 0.33 to 0.17; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3A). Please see Additional file <xref rid="MOESM1" ref-type="media">1</xref> for expected main effects associated with Time.<fig id="Fig2"><label>Fig. 2</label><caption><p>Box-and-scatter plots depicting primary point-of-care (POC; Panel <bold>A</bold>) and invasive hemodynamic (Hemo; Panels <bold>B</bold> and <bold>C</bold>) markers for EE-3-SO<sub>4</sub> (filled circles) and Placebo (unfilled circles) cohorts. Data points are presented at collection times corresponding to Table <xref rid="Tab1" ref-type="table">1</xref>, with POC measurements (glucose, lactate, bicarbonate [HCO<sub>3</sub>]) occurring at baseline (Base), following drug/Placebo administration (35 m), at hour intervals post-trauma (85 m, 145 m, 205 m), and at the terminal experimental endpoint (Term; ~ 295 min post-traumatic brain injury). Primary hemodynamic markers (shock-index [SI] and pulse-pressure [PP]) were continuously collected over the course of the entire experiment (Panel <bold>B</bold>), with data points displayed for baseline, immediately post-traumatic brain injury (0 m), immediately post blood loss procedure (25 m), at hour intervals post-trauma (85 m and 145 m), and at the terminal endpoint. Panel <bold>C</bold> presents a smaller temporal window to capture the predicted rapid effects (5 and 20 min post-drug) of EE-3-SO<sub>4</sub> administration (significant Group × Time interaction). The asterisk denotes significant Group × Time interaction for PP</p></caption><graphic xlink:href="13054_2021_3844_Fig2_HTML" id="MO2"/></fig></p>
                <p id="Par47">A drug-focused analysis examining primary hemodynamic measures at 5 min and 20 min immediately post-drug administration (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C) demonstrated a significant Group × Time interaction for PP (<italic>F</italic><sub>1,62.00</sub> = 6.33, <italic>p</italic> = 0.014). This interaction was driven by a more rapid recovery of PP in the EE-3-SO<sub>4</sub> (<italic>p</italic> &lt; 0.001; repeated measures <italic>d</italic> = 1.16) relative to the Placebo (<italic>p</italic> &lt; 0.001; repeated measures <italic>d</italic> = 0.47) cohort. No Group effects or interactions were observed for SI values (0.05/2 tests; all <italic>p</italic>’s &gt; 0.025, <italic>d</italic> =  − 0.13) or secondary hemodynamic markers of heart rate and MAP (0.05/2 tests; all <italic>p</italic>’s &gt; 0.025, <italic>d</italic> =  − 0.07 to − 0.05; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3B).</p>
                <p id="Par48">Immunohistochemical results (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A, B) indicated no significant differences for EE-3-SO<sub>4</sub> relative to Placebo for either axonal pathology (APP; cortex only) or BBB breach (IgG extravasation) in the cortex or cerebellum following Bonferroni correction (0.05/3 tests; all <italic>p</italic>’s &gt; 0.017, <italic>d</italic> =  − 0.06 to 0.12). Independent 2 × 2 (Group × Time: 5 min post-injury vs. pre-terminal with skull sensor presence as a covariate) did not demonstrate any Group effects or interactions for primary markers (NFL/UCH-L1/GFAP; Fig. <xref rid="Fig3" ref-type="fig">3</xref>C) following Bonferroni correction (0.05/3 tests; all <italic>p</italic>’s &gt; 0.017, <italic>d</italic> =  − 0.14 to 0.09). Secondary blood biomarkers (Aβ40 and Aβ42; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4) indicated a Group × Time interaction for Aβ40 (<italic>F</italic><sub>1,53.80</sub> = 6.80, <italic>p</italic> = 0.012) that survived Bonferroni correction (0.05/2 = 0.025), whereas there was no Group effect or interaction for Aβ42 (<italic>p</italic>’s &gt; 0.025; <italic>d</italic> =  − 0.25). The Aβ40 was characterized by a faster recovery in the EE-3-SO<sub>4</sub> (<italic>p</italic> &lt; 0.001; repeated measures <italic>d</italic> = 0.54) cohort across time relative to the Placebo (<italic>p</italic> &lt; 0.001; repeated measures <italic>d</italic> = 0.26) cohort, partially driven by a higher Aβ40 value immediately post-drug for the EE-3-SO<sub>4</sub> group.<fig id="Fig3"><label>Fig. 3</label><caption><p>Panel <bold>A</bold> depicts immunohistochemistry (IHC) data for 2 animals from the EE-3-SO<sub>4</sub> and Placebo cohorts of both amyloid precursor protein (APP) and Immunoglobulin G (IgG) at the level of the caudate nucleus near the second ventricle. Panel <bold>B</bold> depicts box-and-scatter plots of immunohistochemistry data for EE-3-SO<sub>4</sub> (filled circles) and Placebo (unfilled circles) cohorts for the percentage of cortical (Cort) pixels presenting as positive for staining in both APP and IgG, including at the level of the cerebellum (Cblm) for IgG. Panel <bold>C</bold> presents box-and-scatter plots for primary blood biomarkers of glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) collected at baseline (Base), following drug/Placebo administration (35 m), and at the terminal experimental endpoint (Term; ~ 295 min post-traumatic brain injury). None of the main effects or interactions associated with the Group variable (EE-3-SO<sub>4</sub> vs. Placebo) were significant following Bonferroni correction</p></caption><graphic xlink:href="13054_2021_3844_Fig3_HTML" id="MO3"/></fig></p>
              </sec>
              <sec id="Sec8">
                <title>Secondary analyses</title>
                <p id="Par49">In terms of overall group composition, results indicated that there was approximately a twofold increase (<italic>χ</italic><sup>2</sup> = 8.17, <italic>p</italic> = 0.004) in the proportion of males in the non-surviving (13/16; 81.3%) versus the surviving group (21/52; 40.4%). There were no differences between the non-surviving and matched surviving samples for other demographics (age and weight) or indices of trauma (peak velocity, time to peak, deceleration time, time between TBI and end of blood loss, and blood loss volume). There were no differences between baseline point-of-care measures, invasive hemodynamic markers, or blood-based biomarkers (all <italic>p</italic>’s &gt; 0.05).</p>
                <p id="Par50">All point-of-care (Fig. <xref rid="Fig4" ref-type="fig">4</xref>A) and invasive hemodynamic measurement (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B) analyses were performed on the last available measurement (prior to moribund criteria being met), and controlled for baseline levels and acquisition time post-injury. Glucose was the sole primary point-of-care variable exhibiting a significant effect, but was higher in surviving relative to non-surviving animals (<italic>F</italic><sub>1,20</sub> = 5.76, <italic>p</italic> = 0.026, <italic>d</italic> = 0.98), whereas HCO<sub>3</sub> (<italic>d</italic> = 0.80) and lactate (<italic>d</italic> =  − 0.66) exhibited medium to large effect sizes but were non-significant at current sample sizes (both <italic>p</italic>’s &gt; 0.05). Analysis of secondary point-of-care variables indicated significantly lower pH values (<italic>F</italic><sub>1,20</sub> = 7.26, <italic>p</italic> = 0.014, <italic>d</italic> = 1.13) and elevated K (<italic>F</italic><sub>1,19</sub> = 5.98, <italic>p</italic> = 0.024, <italic>d</italic> =  − 1.03) for non-surviving animals. No primary or secondary invasive hemodynamic measurement was significant for survival status (all <italic>p</italic>’s &gt; 0.05, <italic>d</italic> =  − 0.40 to 0.66). NFL values (<italic>F</italic><sub>1,19</sub> = 12.72, <italic>p</italic> = 0.002, <italic>d</italic> =  − 1.46) were significantly higher for non-surviving animals among primary blood protein markers (Fig. <xref rid="Fig4" ref-type="fig">4</xref>C). Both GFAP (<italic>d</italic> =  − 0.72) and UCH-L1 (<italic>d</italic> =  − 0.74) were not statistically significant, but exhibited medium effect sizes in a similar direction indicating higher pathology (<italic>p</italic>’s &gt; 0.05). Similarly, secondary blood-based biomarkers demonstrated significantly higher levels in non-surviving versus Surviving animals for Aβ42 (<italic>F</italic><sub>1,19</sub> = 5.66, <italic>p</italic> = 0.028, <italic>d</italic> =  − 0.97), with a null Group effect observed for Aβ40 (<italic>p</italic> &gt; 0.05, <italic>d</italic> =  − 0.60).<fig id="Fig4"><label>Fig. 4</label><caption><p>Box-and-scatter plots depicting all primary and significant secondary variables from point-of-care (POC; Panel <bold>A</bold>), invasive hemodynamic (Hemo; Panel <bold>B</bold>), and blood protein (Panel <bold>C</bold>) markers for survival analyses. All data were obtained from the last available, non-terminal timepoint for the non-surviving cohort, and the equivalent time point for each animal’s match (Surviving cohort). Graphed data have been residualized (Rsd.) to account for the effects of initial baseline values and varying measurement acquisition time post-injury. In the case of larger adjustments, this means that negative values are possible. Plots for primary POC measurements (glucose, lactate, bicarbonate [HCO<sub>3</sub>]), significant secondary POC measurements (potassium [K], potential hydrogen [pH]), primary hemodynamic measurements (shock-index [SI] and pulse-pressure [PP]), primary blood protein markers (neurofilament light chain [NFL], ubiquitin C-terminal hydrolase [UCH-L1], glial fibrillary acidic protein [GFAP]) and significant secondary protein markers (amyloid-beta 42 [Aβ42]) are displayed. Asterisks denote significant main effects of Survival Status</p></caption><graphic xlink:href="13054_2021_3844_Fig4_HTML" id="MO4"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec9">
              <title>Discussion</title>
              <p id="Par51">Blood products are not always available in extreme circumstances [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], necessitating the development of novel agents that can both augment the body’s natural response to severe blood loss and mitigate pathological aspects of shock [<xref ref-type="bibr" rid="CR4">4</xref>]. The current study examined the efficacy of EE-3-SO<sub>4</sub> as a treatment for TBI + HS in an austere environment (no mechanical ventilation post-injury, no additional resuscitation fluids, no craniotomy), as frequently occurs in military trauma scenarios and in developing countries [<xref ref-type="bibr" rid="CR32">32</xref>]. The blocked randomization procedures adequately controlled for all potential major confounders from both demographic variables (non-significant differences in animal age, weight and sex) and experimental (statistically equivalent TBI exposure parameters, pre-injury anesthetic time, blood loss levels, etc.) procedures. Current results replicated previous findings of metabolic derangements, a decrease in MAP in conjunction with increased heart-rate, and both blood-based and immunohistochemical evidence of diffuse axonal injury and blood brain barrier disruption in a large animal model of closed-head accelerative TBI + HS [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
              <p id="Par52">The administration of EE-3-SO<sub>4</sub> increased survival rate, normalized pulse pressure immediately post-drug, and provided preliminary evidence of neuroprotection relative to the Placebo cohort in this fully blinded trial. Previous studies have demonstrated increased survival rates and times for rodent and swine models of HS following intravenous EE-3-SO<sub>4</sub> administration [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Current findings extend these results to a large animal model of TBI + HS with approximately 40% blood loss, with EE-3-SO<sub>4</sub> significantly prolonging survival rate relative to a control cohort (90.3% vs. 72.7%, respectively), albeit at a smaller magnitude relative to previous studies of isolated and severe HS [<xref ref-type="bibr" rid="CR15">15</xref>]. The mortality rate observed in the Placebo cohort was also roughly commensurate with reported Class III–IV trauma rates [<xref ref-type="bibr" rid="CR13">13</xref>], providing additional external validity for the closed-head TBI + HS model.</p>
              <p id="Par53">The majority of animals in both groups expired from respiratory distress rather than cardiovascular factors, similar to a previous TBI + HS swine model with 55% blood loss [<xref ref-type="bibr" rid="CR32">32</xref>]. Acute respiratory failure represents the leading cause of death in preclinical models of isolated TBI [<xref ref-type="bibr" rid="CR9">9</xref>], complicates clinical care of TBI patients [<xref ref-type="bibr" rid="CR37">37</xref>], and is more common following TBI + HS relative to HS alone [<xref ref-type="bibr" rid="CR10">10</xref>]. The current study did not directly quantify the presence of congestion, edema, hemorrhage or microatelectasis in pulmonary tissue as has been done in previous swine models [<xref ref-type="bibr" rid="CR38">38</xref>], complicating the dissociation of central nervous system involvement in respiratory failure due to TBI. Mechanical ventilation remains the first line of defense for managing acute respiratory distress syndrome in both pre-hospital and hospital setting following complex trauma [<xref ref-type="bibr" rid="CR39">39</xref>] and is typically used during all phases of preclinical trauma models [<xref ref-type="bibr" rid="CR3">3</xref>]. However, mechanical ventilation is not available as a treatment option in austere environments to combat respiratory distress, representing a potentially critical factor that should be more carefully considered in future studies for full bench-to-bedside translation.</p>
              <p id="Par54">EE-3-SO<sub>4</sub> also more rapidly restored pulse pressure post-administration relative to Placebo, followed by statistically equivalent pressures for the remainder of the experiment. The rapid action of EE-3-SO<sub>4</sub> on pulse pressure suggests direct activation of estrogen receptors rather than through genomic signaling [<xref ref-type="bibr" rid="CR20">20</xref>]. The membrane receptor effects of estrogen include activation of endothelial nitric oxide synthase and the consequent production of nitric oxide, as well as endothelial-independent, rapid mobilization and release of calcium within subcellular compartments leading to increases in Caþþ-triggered Kþ channel activity [<xref ref-type="bibr" rid="CR22">22</xref>]. Activation of these receptors collectively results in changes to myocardial contractility and vasodilation of vascular smooth muscle [<xref ref-type="bibr" rid="CR20">20</xref>]. Over-exuberant vasodilation in the face of severe hypovolemia could be detrimental, but initial vasodilation could also moderate the intense peripheral vasoconstriction seen in TBI + HS, and contribute to the normalization of pulse pressure.</p>
              <p id="Par55">Replication analyses indicated significant post-injury changes in all point-of-care markers of acidosis and other metabolic derangements (glucose, lactate, bicarbonate, etc.), the majority of which did not recover to baseline levels at the end of the 5 h monitoring period. Several of point-of-care markers (pH and potassium) were significantly more affected in non-surviving relative to surviving animals <italic>prior to</italic> death, although glucose was unexpectedly higher for surviving animals. Acidosis represents one of the hallmark complications of HS, and non-surviving animals were unable to compensate from a hemodynamic perspective, ultimately resulting in even further increases in oxygen debt at the tissue level [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. With the exception of glucose, current findings also partially replicate a previous swine model of severe hemorrhage, which reported that increased glucose/potassium/lactate and decreased bicarbonate/MAP were associated with survival [<xref ref-type="bibr" rid="CR15">15</xref>]. In contrast to previous work in rodents [<xref ref-type="bibr" rid="CR20">20</xref>], EE-3-SO<sub>4</sub> administration did not significantly affect either point-of-care markers or MAP relative to Placebo, suggesting the need for polytherapeutic approaches to further promote survival and more rapidly restore homeostasis following TBI + HS [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
              <p id="Par56">Clinical research studies are increasingly using blood-based protein assays to characterize the extent of neurotrauma both in the acute and chronic injury phases of TBI [<xref ref-type="bibr" rid="CR33">33</xref>]. Previous findings [<xref ref-type="bibr" rid="CR32">32</xref>] of significant changes in NFL, GFAP and Aβ42 were replicated in our swine models of accelerative TBI + HS, with UCH-L1 and Aβ40 also significant in the current study due to increased statistical power. Several of these blood-based biomarkers demonstrated sensitivity to injury as soon as 35 min post-TBI and were strongly associated with survival, suggesting potential prognostic indications and a portable test for TBI [<xref ref-type="bibr" rid="CR41">41</xref>]. Similarly, immunohistochemical evidence of diffuse axonal injury (periventricular region only) and blood–brain barrier breach (both periventricular and cerebellar regions) were also present, with previous research suggesting a close coupling between these pathologies [<xref ref-type="bibr" rid="CR42">42</xref>–<xref ref-type="bibr" rid="CR44">44</xref>]. In contrast, there were no significant differences between the Placebo and Sham cohorts on an immunohistochemical marker of inflammation (IBA1) following correction for multiple comparisons. The lack a neuroinflammatory response most likely reflects the relatively brief, 5-h post-injury monitoring period employed in the current study, as neuroinflammation has been shown to be present for multiple years post-injury following TBI [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
              <p id="Par57">Estrogen sulfate has been shown to increase cerebral perfusion pressure, increase partial brain oxygen pressure and decrease intracranial pressure, but not to affect markers of diffuse axonal injury in a previous rodent study [<xref ref-type="bibr" rid="CR30">30</xref>]. Contrary to our a priori predictions, EE-3-SO<sub>4</sub> showed evidence of normalizing plasma levels of Aβ40 rather than biomarkers traditionally associated with blood brain barrier breach or neuroinflammation. Aβ is a 40–42 amino acid long peptide generated by successive cleavage of amyloid pre-cursor protein by β-secretase followed by γ-secretase [<xref ref-type="bibr" rid="CR44">44</xref>]. Although Aβ42 is believed to be more toxic, both forms have been shown to be rapidly released post-TBI, persist for weeks to months post-injury, and are typically viewed as potential markers of diffuse axonal injury [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Numerous preclinical studies have suggested neuroprotective effects for 17β-estradiol [<xref ref-type="bibr" rid="CR48">48</xref>], although estradiol is also elevated post-TBI and has been shown to confer an increased risk of death in severe human TBI [<xref ref-type="bibr" rid="CR49">49</xref>]. However, it remains unknown whether the elevated levels of estradiol post-TBI are due to decreased metabolism (i.e., hydroxylation of estradiol to estrone or increased synthesis due to increased aromatase activity). Although promising, current findings of a more rapid recovery in plasma Aβ40 following EE-3-SO<sub>4</sub> administration require further replication given the lack of efficacy for other female steroidal hormones in clinical TBI trials [<xref ref-type="bibr" rid="CR50">50</xref>] and current null findings for APP immunohistochemistry.</p>
              <p id="Par58">In the current study, male sex was associated with a nearly twofold increase in mortality rate regardless of drug assignment. There is a rich preclinical literature suggesting that biological sex and associated female endogenous steroidal hormones affect systematic responses to both blunt force and neurotrauma, but with mixed findings in clinical studies [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. Specifically, retrospective clinical studies suggest that female sex may be protective against blunt-force trauma complications such as organ failure and sepsis rather than confer a benefit in terms of mortality [<xref ref-type="bibr" rid="CR53">53</xref>–<xref ref-type="bibr" rid="CR55">55</xref>]. Other clinical studies have suggested that only perimenopausal or postmenopausal females demonstrate decreased mortality following isolated moderate to severe TBI [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>], whereas pediatric-focused TBI studies indicated increased survival only for post-pubescent females [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. The latter more closely corresponds to the approximate age of the swine used in the current study and potentially suggests a U shaped relationship between female sex and neuroprotection as a function of age.
</p>
              <p id="Par59">There are several limitations to the study that should be noted. First, the current study purposefully did not measure several physiological functions (cerebral perfusion pressure, partial brain oxygen pressure, intracranial pressure, etc.) due to their invasive nature. The study design was intentionally focused on point-of-care and blood based biomarkers that can readily be performed in humans relative to more sophisticated immunohistochemical assays, and our aim to examine a more realistic closed head injury (i.e., intact skull). Blood samples and embedded brain tissue from this study will be made available upon request for additional, secondary analyses. Second, all animals received anesthesia throughout the entire protocol in compliance with the approved ethical framework for this study. Although this is unlikely to have influenced drug-related outcomes due to the fully randomized and blinded design, it may have artificially inflated mortality rates associated with respiratory depression across both cohorts. The selected anesthetic regimen partially mitigated this confounder through utilization of agents that minimize respiratory depression (i.e., midazolam and ketamine) relative to isoflurane, but in doing so also potentially increased neuroprotective effects [<xref ref-type="bibr" rid="CR60">60</xref>]. Finally, animals were only monitored for up 5 h post-injury in the current study, which limits the conclusions that can be drawn about more long-term therapeutic effects of EE-3-SO<sub>4</sub> or long-term pathophysiological consequences of the TBI + HS model.</p>
            </sec>
            <sec id="Sec10">
              <title>Conclusions</title>
              <p id="Par60">In summary, blood products (whole blood, plasma, etc.) represent the treatment of choice for severe blood loss with or without a concomitant TBI, but are not always available [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Current results provide additional support for the efficacy of EE-3-SO<sub>4</sub> to promote survival following HS and TBI + HS in austere environments in the absence of fluid resuscitation [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], along with additional salutary effects on hemodynamics. Poly-therapeutic approaches that target additional mechanisms (increased hemostasis, oxygen carrying capacity, etc.) for promoting survival to complement the beneficial effects of EE-3-SO<sub>4</sub> should be considered in future studies, along with more in-depth characterization of how EE-3-SO<sub>4</sub> potentially mitigates neuronal and pulmonary injury.
</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec11">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="13054_2021_3844_MOESM1_ESM.docx">
                      <caption>
                        <p><bold>Additional file 1.</bold> Supplemental Materials.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>Aβ40</term>
                  <def>
                    <p id="Par5">Amyloid beta 40</p>
                  </def>
                </def-item>
                <def-item>
                  <term>Aβ42</term>
                  <def>
                    <p id="Par6">Amyloid beta 42</p>
                  </def>
                </def-item>
                <def-item>
                  <term>APP</term>
                  <def>
                    <p id="Par7">Amyloid precursor protein</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BBB</term>
                  <def>
                    <p id="Par8">Blood–brain barrier</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EE-3-SO<sub>4</sub></term>
                  <def>
                    <p id="Par9">Estradiol-3-sulfate</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GFAP</term>
                  <def>
                    <p id="Par10">Glial fibrillary acidic protein</p>
                  </def>
                </def-item>
                <def-item>
                  <term>GLM</term>
                  <def>
                    <p id="Par11">General linear models</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HCO<sub>3</sub></term>
                  <def>
                    <p id="Par12">Bicarbonate</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HS</term>
                  <def>
                    <p id="Par13">Hemorrhagic shock</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IBA1</term>
                  <def>
                    <p id="Par14">Ionized calcium-binding adaptor molecule 1</p>
                  </def>
                </def-item>
                <def-item>
                  <term>iCa</term>
                  <def>
                    <p id="Par15">Ionized calcium</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IgG</term>
                  <def>
                    <p id="Par16">Immunoglobulin G</p>
                  </def>
                </def-item>
                <def-item>
                  <term>K</term>
                  <def>
                    <p id="Par17">Potassium</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LME</term>
                  <def>
                    <p id="Par18">Linear mixed effects</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MAP</term>
                  <def>
                    <p id="Par19">Mean arterial pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term>Na</term>
                  <def>
                    <p id="Par20">Sodium</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NFL</term>
                  <def>
                    <p id="Par21">Neurofilament light</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PCO<sub>2</sub></term>
                  <def>
                    <p id="Par22">Partial CO<sub>2</sub> pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term>pH</term>
                  <def>
                    <p id="Par23">Potential hydrogen</p>
                  </def>
                </def-item>
                <def-item>
                  <term>PP</term>
                  <def>
                    <p id="Par24">Pulse pressure</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SI</term>
                  <def>
                    <p id="Par25">Shock index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>TBI</term>
                  <def>
                    <p id="Par26">Traumatic brain injury</p>
                  </def>
                </def-item>
                <def-item>
                  <term>UCH-L1</term>
                  <def>
                    <p id="Par27">Ubiquitin C-terminal hydrolase L1</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>We would also like to thank Mandy Pacheco, Fawn Reed, Sheila Alonzo, Jaime Leo and Jimmy Gonzales for help with data collection.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors' contributions</title>
              <p>CM, MV, AG, AL, JG, EE, CL, MV, VG, DS, VS, CRB and SPR analyzed data. AD drafted the tables and figures. AM, DS, VS, AD, RK and IC interpreted the data and drafted the manuscript. AM designed the study protocol and supervised the study. JL, RD, JRL, AM and AD collected data. RK collected and analyzed data. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This research was supported by a grant from the Departments of Defense (W81XWH-17-2-0052) to Andrew R. Mayer. Histological analysis was performed by the Preclinical Clinical Core Facility at the University of New Mexico Center for Brain Recovery and Repair, which is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant Number P20GM109089.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The data sets used and/or analyzed during the current study are available from the corresponding author on request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par61">All animal procedures (see Table <xref rid="Tab1" ref-type="table">1</xref> for summary) were approved by the local Institutional Animal Care and Use Committee (Lovelace Biomedical, FY17-077, FY20-133) and the U.S. Army Medical Research &amp; Development Command Office of Research Protections Animal Care and Use Review Office (DM160115, DM160115.e001) prior to study initiation.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par62">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par63">The authors have no conflicts of interest to disclose.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Eastridge</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <name>
                      <surname>Mabry</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>Seguin</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Cantrell</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Tops</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Uribe</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Death on the battlefield (2001–2011): implications for the future of combat casualty care</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2012</year>
                  <volume>73</volume>
                  <issue>6 Suppl 5</issue>
                  <fpage>S431</fpage>
                  <lpage>S437</lpage>
                  <?supplied-pmid 23192066?>
                  <pub-id pub-id-type="pmid">23192066</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shafi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Collinsworth</surname>
                      <given-names>AW</given-names>
                    </name>
                    <name>
                      <surname>Richter</surname>
                      <given-names>KM</given-names>
                    </name>
                    <name>
                      <surname>Alam</surname>
                      <given-names>HB</given-names>
                    </name>
                    <name>
                      <surname>Becker</surname>
                      <given-names>LB</given-names>
                    </name>
                    <name>
                      <surname>Bullock</surname>
                      <given-names>MR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Bundles of care for resuscitation from hemorrhagic shock and severe brain injury in trauma patients—translating knowledge into practice</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2016</year>
                  <volume>81</volume>
                  <issue>4</issue>
                  <fpage>780</fpage>
                  <lpage>794</lpage>
                  <?supplied-pmid 27389129?>
                  <pub-id pub-id-type="pmid">27389129</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayer</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Dodd</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Vermillion</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Stephenson</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                    <name>
                      <surname>Bragin</surname>
                      <given-names>DE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A systematic review of large animal models of combined traumatic brain injury and hemorrhagic shock</article-title>
                  <source>Neurosci Biobehav Rev</source>
                  <year>2019</year>
                  <volume>104</volume>
                  <fpage>160</fpage>
                  <lpage>177</lpage>
                  <?supplied-pmid 31255665?>
                  <pub-id pub-id-type="pmid">31255665</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cannon</surname>
                      <given-names>JW</given-names>
                    </name>
                  </person-group>
                  <article-title>Hemorrhagic shock</article-title>
                  <source>N Engl J Med</source>
                  <year>2018</year>
                  <volume>378</volume>
                  <issue>4</issue>
                  <fpage>370</fpage>
                  <lpage>379</lpage>
                  <?supplied-pmid 29365303?>
                  <pub-id pub-id-type="pmid">29365303</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Matsushita</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Bramlett</surname>
                      <given-names>HM</given-names>
                    </name>
                    <name>
                      <surname>Kuluz</surname>
                      <given-names>JW</given-names>
                    </name>
                    <name>
                      <surname>Alonso</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Dietrich</surname>
                      <given-names>WD</given-names>
                    </name>
                  </person-group>
                  <article-title>Delayed hemorrhagic hypotension exacerbates the hemodynamic and histopathologic consequences of traumatic brain injury in rats</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <year>2001</year>
                  <volume>21</volume>
                  <issue>7</issue>
                  <fpage>847</fpage>
                  <lpage>856</lpage>
                  <?supplied-pmid 11435797?>
                  <pub-id pub-id-type="pmid">11435797</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vella</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Crandall</surname>
                      <given-names>ML</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>MB</given-names>
                    </name>
                  </person-group>
                  <article-title>Acute management of traumatic brain injury</article-title>
                  <source>Surg Clin North Am</source>
                  <year>2017</year>
                  <volume>97</volume>
                  <issue>5</issue>
                  <fpage>1015</fpage>
                  <lpage>1030</lpage>
                  <?supplied-pmid 28958355?>
                  <pub-id pub-id-type="pmid">28958355</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muller</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Courelli</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Lucas</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Dos</surname>
                      <given-names>SF</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Resuscitation from hemorrhagic shock after traumatic brain injury with polymerized hemoglobin</article-title>
                  <source>Sci Rep</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>2509</fpage>
                  <?supplied-pmid 33510204?>
                  <pub-id pub-id-type="pmid">33510204</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierrez</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Das</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ballarino</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Beyzaei-Arani</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Turkan</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wulf-Gutierrez</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Decreased respiratory rate variability during mechanical ventilation is associated with increased mortality</article-title>
                  <source>Intensive Care Med</source>
                  <year>2013</year>
                  <volume>39</volume>
                  <issue>8</issue>
                  <fpage>1359</fpage>
                  <lpage>1367</lpage>
                  <?supplied-pmid 23743521?>
                  <pub-id pub-id-type="pmid">23743521</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiong</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Mahmood</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Chopp</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Animal models of traumatic brain injury</article-title>
                  <source>Nat Rev Neurosci</source>
                  <year>2013</year>
                  <volume>14</volume>
                  <issue>2</issue>
                  <fpage>128</fpage>
                  <lpage>142</lpage>
                  <?supplied-pmid 23329160?>
                  <pub-id pub-id-type="pmid">23329160</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Galvagno</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Appana</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Baraniuk</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bosarge</surname>
                      <given-names>PL</given-names>
                    </name>
                    <name>
                      <surname>Bulger</surname>
                      <given-names>EM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Outcomes after concomitant traumatic brain injury and hemorrhagic shock: a secondary analysis from the pragmatic, randomized optimal platelets and plasma ratios trial</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2017</year>
                  <volume>83</volume>
                  <issue>4</issue>
                  <fpage>668</fpage>
                  <lpage>674</lpage>
                  <?supplied-pmid 28930959?>
                  <pub-id pub-id-type="pmid">28930959</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Butler</surname>
                      <given-names>FK</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Holcomb</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Shackelford</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Barbabella</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>JA</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>JB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Advanced resuscitative care in tactical combat casualty care: TCCC guidelines change 18–01:14 October 2018</article-title>
                  <source>J Spec Oper Med</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <issue>4</issue>
                  <fpage>37</fpage>
                  <lpage>55</lpage>
                  <?supplied-pmid 30566723?>
                  <pub-id pub-id-type="pmid">30566723</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Callcut</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Kornblith</surname>
                      <given-names>LZ</given-names>
                    </name>
                    <name>
                      <surname>Conroy</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Robles</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Meizoso</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Namias</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The why and how our trauma patients die: a prospective Multicenter Western Trauma Association study</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2019</year>
                  <volume>86</volume>
                  <issue>5</issue>
                  <fpage>864</fpage>
                  <lpage>870</lpage>
                  <?supplied-pmid 30633095?>
                  <pub-id pub-id-type="pmid">30633095</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>American College of Surgeons Committee on Trauma</collab>
                  </person-group>
                  <source>Advanced trauma life support program for doctors</source>
                  <year>2004</year>
                  <edition>7</edition>
                  <publisher-loc>Chicago</publisher-loc>
                  <publisher-name>American College of Surgeons</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>HP</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of estrogen and receptor agonists in maintaining organ function after trauma-hemorrhage</article-title>
                  <source>Shock</source>
                  <year>2009</year>
                  <volume>31</volume>
                  <issue>3</issue>
                  <fpage>227</fpage>
                  <lpage>237</lpage>
                  <?supplied-pmid 18665049?>
                  <pub-id pub-id-type="pmid">18665049</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Keith</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Berman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Burlington</surname>
                      <given-names>DB</given-names>
                    </name>
                    <name>
                      <surname>Grudzinskas</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>W</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Efficacy of 17alpha-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitation</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2014</year>
                  <volume>76</volume>
                  <issue>6</issue>
                  <fpage>1409</fpage>
                  <lpage>1416</lpage>
                  <?supplied-pmid 24854309?>
                  <pub-id pub-id-type="pmid">24854309</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ardelt</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>McCullough</surname>
                      <given-names>LD</given-names>
                    </name>
                    <name>
                      <surname>Korach</surname>
                      <given-names>KS</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Munzenmaier</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Hurn</surname>
                      <given-names>PD</given-names>
                    </name>
                  </person-group>
                  <article-title>Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model</article-title>
                  <source>Stroke</source>
                  <year>2005</year>
                  <volume>36</volume>
                  <issue>2</issue>
                  <fpage>337</fpage>
                  <lpage>341</lpage>
                  <?supplied-pmid 15637314?>
                  <pub-id pub-id-type="pmid">15637314</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Heidenreich</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>The use of estrogen for the treatment of traumatic brain injury</article-title>
                  <source>New therapeutics for traumatic brain injury</source>
                  <year>2017</year>
                  <publisher-loc>Cambridge</publisher-loc>
                  <publisher-name>Academic Press</publisher-name>
                  <fpage>161</fpage>
                  <lpage>177</lpage>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Not</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Chatham</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Choudhry</surname>
                      <given-names>MA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>17beta-estradiol(E2) administration after major blood loss improves liver ATP, 3-h survival and also long-term survival following prolonged hypotension (3 h) and fluid resuscitation</article-title>
                  <source>Shock</source>
                  <year>2006</year>
                  <volume>25</volume>
                  <issue>6</issue>
                  <fpage>11</fpage>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Zinn</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Fineberg</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Single photon emission computed tomography demonstrated efficacy of 17ß-estradiol therapy in male rats after trauma-hemorrhage and extended hypotension</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2010</year>
                  <volume>69</volume>
                  <issue>5</issue>
                  <fpage>1266</fpage>
                  <lpage>1273</lpage>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Ethinyl estradiol sulfate acts without fluid resuscitation through estrogen receptors to rapidly protect the cardiovascular system from severe hemorrhage</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2021</year>
                  <volume>90</volume>
                  <issue>2</issue>
                  <fpage>353</fpage>
                  <lpage>359</lpage>
                  <?supplied-pmid 33048911?>
                  <pub-id pub-id-type="pmid">33048911</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Keith</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Berman</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Peck</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>17alpha-Ethynylestradiol-3-sulfate treatment of severe blood loss in rats</article-title>
                  <source>J Surg Res</source>
                  <year>2015</year>
                  <volume>193</volume>
                  <issue>1</issue>
                  <fpage>355</fpage>
                  <lpage>360</lpage>
                  <?supplied-pmid 25085704?>
                  <pub-id pub-id-type="pmid">25085704</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yu</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Barman</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Sellers</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Stallone</surname>
                      <given-names>JN</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle</article-title>
                  <source>Am J Physiol Endocrinol Metab</source>
                  <year>2011</year>
                  <volume>301</volume>
                  <issue>5</issue>
                  <fpage>E882</fpage>
                  <lpage>E888</lpage>
                  <?supplied-pmid 21791623?>
                  <pub-id pub-id-type="pmid">21791623</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hsieh</surname>
                      <given-names>YC</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>HP</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Choudhry</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Schwacha</surname>
                      <given-names>MG</given-names>
                    </name>
                    <name>
                      <surname>Bland</surname>
                      <given-names>KI</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage</article-title>
                  <source>J Mol Cell Cardiol</source>
                  <year>2006</year>
                  <volume>41</volume>
                  <issue>3</issue>
                  <fpage>511</fpage>
                  <lpage>521</lpage>
                  <?supplied-pmid 16859701?>
                  <pub-id pub-id-type="pmid">16859701</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>SJ</given-names>
                    </name>
                    <name>
                      <surname>McEwen</surname>
                      <given-names>BS</given-names>
                    </name>
                  </person-group>
                  <article-title>Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications</article-title>
                  <source>Annu Rev Pharmacol Toxicol</source>
                  <year>2001</year>
                  <volume>41</volume>
                  <fpage>569</fpage>
                  <lpage>591</lpage>
                  <?supplied-pmid 11264469?>
                  <pub-id pub-id-type="pmid">11264469</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sohrabji</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Guarding the blood–brain barrier: a role for estrogen in the etiology of neurodegenerative disease</article-title>
                  <source>Gene Expr</source>
                  <year>2007</year>
                  <volume>13</volume>
                  <issue>6</issue>
                  <fpage>311</fpage>
                  <lpage>319</lpage>
                  <?supplied-pmid 17708417?>
                  <pub-id pub-id-type="pmid">17708417</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ardelt</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Anjum</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Rajneesh</surname>
                      <given-names>KF</given-names>
                    </name>
                    <name>
                      <surname>Kulesza</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Koehler</surname>
                      <given-names>RC</given-names>
                    </name>
                  </person-group>
                  <article-title>Estradiol augments peri-infarct cerebral vascular density in experimental stroke</article-title>
                  <source>Exp Neurol</source>
                  <year>2007</year>
                  <volume>206</volume>
                  <issue>1</issue>
                  <fpage>95</fpage>
                  <lpage>100</lpage>
                  <?supplied-pmid 17509567?>
                  <pub-id pub-id-type="pmid">17509567</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O'Donnell</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Lam</surname>
                      <given-names>TI</given-names>
                    </name>
                    <name>
                      <surname>Tran</surname>
                      <given-names>LQ</given-names>
                    </name>
                    <name>
                      <surname>Foroutan</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>SE</given-names>
                    </name>
                  </person-group>
                  <article-title>Estradiol reduces activity of the blood–brain barrier Na–K–Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion</article-title>
                  <source>J Cereb Blood Flow Metab</source>
                  <year>2006</year>
                  <volume>26</volume>
                  <issue>10</issue>
                  <fpage>1234</fpage>
                  <lpage>1249</lpage>
                  <?supplied-pmid 16421506?>
                  <pub-id pub-id-type="pmid">16421506</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Akabori</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Moeinpour</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Bland</surname>
                      <given-names>KI</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanism of the anti-inflammatory effect of 17beta-estradiol on brain following trauma-hemorrhage</article-title>
                  <source>Shock</source>
                  <year>2010</year>
                  <volume>33</volume>
                  <issue>1</issue>
                  <fpage>43</fpage>
                  <lpage>48</lpage>
                  <?supplied-pmid 19536048?>
                  <pub-id pub-id-type="pmid">19536048</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Day</surname>
                      <given-names>NL</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>CL</given-names>
                    </name>
                    <name>
                      <surname>D'Alessandro</surname>
                      <given-names>TL</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>17beta-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1</article-title>
                  <source>J Neurotrauma</source>
                  <year>2013</year>
                  <volume>30</volume>
                  <issue>17</issue>
                  <fpage>1531</fpage>
                  <lpage>1541</lpage>
                  <?supplied-pmid 23659385?>
                  <pub-id pub-id-type="pmid">23659385</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Cam-Etoz</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Zhai</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>WJ</given-names>
                    </name>
                    <name>
                      <surname>Zinn</surname>
                      <given-names>KR</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Salutary effects of estrogen sulfate for traumatic brain injury</article-title>
                  <source>J Neurotrauma</source>
                  <year>2015</year>
                  <volume>32</volume>
                  <issue>16</issue>
                  <fpage>1210</fpage>
                  <lpage>1216</lpage>
                  <?supplied-pmid 25646701?>
                  <pub-id pub-id-type="pmid">25646701</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taylor</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Bell</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Breiding</surname>
                      <given-names>MJ</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013</article-title>
                  <source>MMWR Surveill Summ</source>
                  <year>2017</year>
                  <volume>66</volume>
                  <issue>9</issue>
                  <fpage>1</fpage>
                  <lpage>16</lpage>
                  <?supplied-pmid 28301451?>
                  <pub-id pub-id-type="pmid">28301451</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayer</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Dodd</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Ling</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Stephenson</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Rannou-Latella</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Vermillion</surname>
                      <given-names>MS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Survival rates and biomarkers in a large animal model of traumatic brain injury combined with two different levels of blood loss</article-title>
                  <source>Shock</source>
                  <year>2021</year>
                  <volume>55</volume>
                  <issue>4</issue>
                  <fpage>554</fpage>
                  <lpage>562</lpage>
                  <?supplied-pmid 32881755?>
                  <pub-id pub-id-type="pmid">32881755</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zetterberg</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Blennow</surname>
                      <given-names>K</given-names>
                    </name>
                  </person-group>
                  <article-title>Fluid biomarkers for mild traumatic brain injury and related conditions</article-title>
                  <source>Nat Rev Neurol</source>
                  <year>2016</year>
                  <volume>12</volume>
                  <issue>10</issue>
                  <fpage>563</fpage>
                  <lpage>574</lpage>
                  <?supplied-pmid 27632903?>
                  <pub-id pub-id-type="pmid">27632903</pub-id>
                </element-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">du Percie SN, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br J Pharmacol. 2020;177(16):3617–24.</mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mayer</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Ling</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Dodd</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Rannou-Latella</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Stephenson</surname>
                      <given-names>DD</given-names>
                    </name>
                    <name>
                      <surname>Dodd</surname>
                      <given-names>RJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Reproducibility and characterization of head kinematics during a large animal acceleration model of traumatic brain injury</article-title>
                  <source>Front Neurol</source>
                  <year>2021</year>
                  <volume>12</volume>
                  <fpage>658461</fpage>
                  <?supplied-pmid 34177763?>
                  <pub-id pub-id-type="pmid">34177763</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koh</surname>
                      <given-names>EY</given-names>
                    </name>
                    <name>
                      <surname>Oyeniyi</surname>
                      <given-names>BT</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Scerbo</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Tomasek</surname>
                      <given-names>JS</given-names>
                    </name>
                    <name>
                      <surname>Wade</surname>
                      <given-names>CE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Trends in potentially preventable trauma deaths between 2005–2006 and 2012–2013</article-title>
                  <source>Am J Surg</source>
                  <year>2019</year>
                  <volume>218</volume>
                  <issue>3</issue>
                  <fpage>501</fpage>
                  <lpage>506</lpage>
                  <?supplied-pmid 30595330?>
                  <pub-id pub-id-type="pmid">30595330</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hendrickson</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Howard</surname>
                      <given-names>BM</given-names>
                    </name>
                    <name>
                      <surname>Kornblith</surname>
                      <given-names>LZ</given-names>
                    </name>
                    <name>
                      <surname>Conroy</surname>
                      <given-names>AS</given-names>
                    </name>
                    <name>
                      <surname>Nelson</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Zhuo</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The acute respiratory distress syndrome following isolated severe traumatic brain injury</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2016</year>
                  <volume>80</volume>
                  <issue>6</issue>
                  <fpage>989</fpage>
                  <lpage>997</lpage>
                  <?supplied-pmid 26881489?>
                  <pub-id pub-id-type="pmid">26881489</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Scultetus</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>Jefferson</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Haque</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hubbell</surname>
                      <given-names>JN</given-names>
                    </name>
                    <name>
                      <surname>Arnaud</surname>
                      <given-names>FG</given-names>
                    </name>
                    <name>
                      <surname>Moon-Massat</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Histopathological evidence of multiple organ damage after simulated aeromedical evacuation in a wwine acute lung injury model</article-title>
                  <source>Mil Med</source>
                  <year>2020</year>
                  <volume>185</volume>
                  <issue>Suppl 1</issue>
                  <fpage>57</fpage>
                  <lpage>66</lpage>
                  <?supplied-pmid 32074309?>
                  <pub-id pub-id-type="pmid">32074309</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Noorbakhsh</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Kriley</surname>
                      <given-names>IR</given-names>
                    </name>
                  </person-group>
                  <article-title>Management of severe respiratory failure in complex trauma patients</article-title>
                  <source>J Emerg Crit Care Med March</source>
                  <year>2018</year>
                  <volume>2</volume>
                  <issue>3</issue>
                  <fpage>26</fpage>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hildebrand</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Andruszkow</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Huber-Lang</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Pape</surname>
                      <given-names>HC</given-names>
                    </name>
                    <name>
                      <surname>van Griensven</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Combined hemorrhage/trauma models in pigs-current state and future perspectives</article-title>
                  <source>Shock</source>
                  <year>2013</year>
                  <volume>40</volume>
                  <issue>4</issue>
                  <fpage>247</fpage>
                  <lpage>273</lpage>
                  <?supplied-pmid 23856921?>
                  <pub-id pub-id-type="pmid">23856921</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>KK</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Rubenstein</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Tyndall</surname>
                      <given-names>JA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An update on diagnostic and prognostic biomarkers for traumatic brain injury</article-title>
                  <source>Expert Rev Mol Diagn</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <issue>2</issue>
                  <fpage>165</fpage>
                  <lpage>180</lpage>
                  <?supplied-pmid 29338452?>
                  <pub-id pub-id-type="pmid">29338452</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>VE</given-names>
                    </name>
                    <name>
                      <surname>Weber</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Xiao</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cullen</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Meaney</surname>
                      <given-names>DF</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>W</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mechanical disruption of the blood–brain barrier following experimental concussion</article-title>
                  <source>Acta Neuropathol</source>
                  <year>2018</year>
                  <volume>135</volume>
                  <issue>5</issue>
                  <fpage>711</fpage>
                  <lpage>726</lpage>
                  <?supplied-pmid 29460006?>
                  <pub-id pub-id-type="pmid">29460006</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wojnarowicz</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Minaeva</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Goldstein</surname>
                      <given-names>LE</given-names>
                    </name>
                  </person-group>
                  <article-title>Considerations for experimental animal models of concussion, traumatic brain injury, and chronic traumatic encephalopathy—these matters matter</article-title>
                  <source>Front Neurol</source>
                  <year>2017</year>
                  <volume>8</volume>
                  <fpage>240</fpage>
                  <?supplied-pmid 28620350?>
                  <pub-id pub-id-type="pmid">28620350</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Karran</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>De</surname>
                      <given-names>SB</given-names>
                    </name>
                  </person-group>
                  <article-title>The amyloid cascade hypothesis: are we poised for success or failure?</article-title>
                  <source>J Neurochem</source>
                  <year>2016</year>
                  <volume>139</volume>
                  <issue>Suppl 2</issue>
                  <fpage>237</fpage>
                  <lpage>252</lpage>
                  <?supplied-pmid 27255958?>
                  <pub-id pub-id-type="pmid">27255958</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>VE</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Begbie</surname>
                      <given-names>FD</given-names>
                    </name>
                    <name>
                      <surname>Trojanowski</surname>
                      <given-names>JQ</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Inflammation and white matter degeneration persist for years after a single traumatic brain injury</article-title>
                  <source>Brain</source>
                  <year>2013</year>
                  <volume>136</volume>
                  <issue>Pt 1</issue>
                  <fpage>28</fpage>
                  <lpage>42</lpage>
                  <?supplied-pmid 23365092?>
                  <pub-id pub-id-type="pmid">23365092</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>VE</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>DH</given-names>
                    </name>
                  </person-group>
                  <article-title>Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans</article-title>
                  <source>Brain Pathol</source>
                  <year>2012</year>
                  <volume>22</volume>
                  <issue>2</issue>
                  <fpage>142</fpage>
                  <lpage>149</lpage>
                  <?supplied-pmid 21714827?>
                  <pub-id pub-id-type="pmid">21714827</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Washington</surname>
                      <given-names>PM</given-names>
                    </name>
                    <name>
                      <surname>Morffy</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Parsadanian</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zapple</surname>
                      <given-names>DN</given-names>
                    </name>
                    <name>
                      <surname>Burns</surname>
                      <given-names>MP</given-names>
                    </name>
                  </person-group>
                  <article-title>Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model</article-title>
                  <source>J Neurotrauma</source>
                  <year>2014</year>
                  <volume>31</volume>
                  <issue>1</issue>
                  <fpage>125</fpage>
                  <lpage>134</lpage>
                  <?supplied-pmid 24050316?>
                  <pub-id pub-id-type="pmid">24050316</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kovesdi</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Szabo-Meleg</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Abraham</surname>
                      <given-names>IM</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of estradiol in traumatic brain injury: mechanism and treatment potential</article-title>
                  <source>Int J Mol Sci</source>
                  <year>2020</year>
                  <volume>22</volume>
                  <issue>1</issue>
                  <fpage>11</fpage>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumar</surname>
                      <given-names>RG</given-names>
                    </name>
                    <name>
                      <surname>DiSanto</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Awan</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Vaughan</surname>
                      <given-names>LE</given-names>
                    </name>
                    <name>
                      <surname>Levochkina</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Weppner</surname>
                      <given-names>JL</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Temporal acute serum estradiol and tumor necrosis factor-alpha associations and risk of death after severe traumatic brain injury</article-title>
                  <source>J Neurotrauma</source>
                  <year>2020</year>
                  <volume>37</volume>
                  <issue>20</issue>
                  <fpage>2198</fpage>
                  <lpage>2210</lpage>
                  <?supplied-pmid 32375598?>
                  <pub-id pub-id-type="pmid">32375598</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wright</surname>
                      <given-names>DW</given-names>
                    </name>
                    <name>
                      <surname>Yeatts</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Silbergleit</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Palesch</surname>
                      <given-names>YY</given-names>
                    </name>
                    <name>
                      <surname>Hertzberg</surname>
                      <given-names>VS</given-names>
                    </name>
                    <name>
                      <surname>Frankel</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Very early administration of progesterone for acute traumatic brain injury</article-title>
                  <source>N Engl J Med</source>
                  <year>2014</year>
                  <volume>371</volume>
                  <issue>26</issue>
                  <fpage>2457</fpage>
                  <lpage>2466</lpage>
                  <?supplied-pmid 25493974?>
                  <pub-id pub-id-type="pmid">25493974</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mizushima</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Jarrar</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Cioffi</surname>
                      <given-names>WG</given-names>
                    </name>
                    <name>
                      <surname>Bland</surname>
                      <given-names>KI</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                  </person-group>
                  <article-title>Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals</article-title>
                  <source>Ann Surg</source>
                  <year>2000</year>
                  <volume>232</volume>
                  <issue>5</issue>
                  <fpage>673</fpage>
                  <lpage>679</lpage>
                  <?supplied-pmid 11066139?>
                  <pub-id pub-id-type="pmid">11066139</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Semenas</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Nozari</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Sharma</surname>
                      <given-names>HS</given-names>
                    </name>
                    <name>
                      <surname>Basu</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rubertsson</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wiklund</surname>
                      <given-names>L</given-names>
                    </name>
                  </person-group>
                  <article-title>Sex differences in cerebral injury after severe haemorrhage and ventricular fibrillation in pigs</article-title>
                  <source>Acta Anaesthesiol Scand</source>
                  <year>2010</year>
                  <volume>54</volume>
                  <issue>3</issue>
                  <fpage>343</fpage>
                  <lpage>353</lpage>
                  <?supplied-pmid 19764903?>
                  <pub-id pub-id-type="pmid">19764903</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trentzsch</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Nienaber</surname>
                      <given-names>U</given-names>
                    </name>
                    <name>
                      <surname>Behnke</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lefering</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Piltz</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Female sex protects from organ failure and sepsis after major trauma haemorrhage</article-title>
                  <source>Injury</source>
                  <year>2014</year>
                  <volume>45</volume>
                  <issue>Suppl 3</issue>
                  <fpage>S20</fpage>
                  <lpage>S28</lpage>
                  <?supplied-pmid 25284229?>
                  <pub-id pub-id-type="pmid">25284229</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>George</surname>
                      <given-names>RL</given-names>
                    </name>
                    <name>
                      <surname>McGwin</surname>
                      <given-names>G</given-names>
                      <suffix>Jr</suffix>
                    </name>
                    <name>
                      <surname>Windham</surname>
                      <given-names>ST</given-names>
                    </name>
                    <name>
                      <surname>Melton</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Metzger</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Chaudry</surname>
                      <given-names>IH</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Age-related gender differential in outcome after blunt or penetrating trauma</article-title>
                  <source>Shock</source>
                  <year>2003</year>
                  <volume>19</volume>
                  <issue>1</issue>
                  <fpage>28</fpage>
                  <lpage>32</lpage>
                  <?supplied-pmid 12558140?>
                  <pub-id pub-id-type="pmid">12558140</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sperry</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>Nathens</surname>
                      <given-names>AB</given-names>
                    </name>
                    <name>
                      <surname>Frankel</surname>
                      <given-names>HL</given-names>
                    </name>
                    <name>
                      <surname>Vanek</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Moore</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Maier</surname>
                      <given-names>RV</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible?</article-title>
                  <source>Crit Care Med</source>
                  <year>2008</year>
                  <volume>36</volume>
                  <issue>6</issue>
                  <fpage>1838</fpage>
                  <lpage>1845</lpage>
                  <?supplied-pmid 18496363?>
                  <pub-id pub-id-type="pmid">18496363</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berry</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ley</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Tillou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cryer</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Margulies</surname>
                      <given-names>DR</given-names>
                    </name>
                    <name>
                      <surname>Salim</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of gender on patients with moderate to severe head injuries</article-title>
                  <source>J Trauma</source>
                  <year>2009</year>
                  <volume>67</volume>
                  <issue>5</issue>
                  <fpage>950</fpage>
                  <lpage>953</lpage>
                  <?supplied-pmid 19901653?>
                  <pub-id pub-id-type="pmid">19901653</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <mixed-citation publication-type="other">Hong ZJ, Firek M, Zachary B, Mors K, Schindler C, Marzi I, et al. The effect of age and sex on outcomes following isolated moderate to severe traumatic brain injury. Eur J Trauma Emerg Surg. 2020.</mixed-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ley</surname>
                      <given-names>EJ</given-names>
                    </name>
                    <name>
                      <surname>Short</surname>
                      <given-names>SS</given-names>
                    </name>
                    <name>
                      <surname>Liou</surname>
                      <given-names>DZ</given-names>
                    </name>
                    <name>
                      <surname>Singer</surname>
                      <given-names>MB</given-names>
                    </name>
                    <name>
                      <surname>Mirocha</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Melo</surname>
                      <given-names>N</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gender impacts mortality after traumatic brain injury in teenagers</article-title>
                  <source>J Trauma Acute Care Surg</source>
                  <year>2013</year>
                  <volume>75</volume>
                  <issue>4</issue>
                  <fpage>682</fpage>
                  <lpage>686</lpage>
                  <?supplied-pmid 24064883?>
                  <pub-id pub-id-type="pmid">24064883</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phelan</surname>
                      <given-names>HA</given-names>
                    </name>
                    <name>
                      <surname>Shafi</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Parks</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Maxson</surname>
                      <given-names>RT</given-names>
                    </name>
                    <name>
                      <surname>Ahmad</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>JT</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Use of a pediatric cohort to examine gender and sex hormone influences on outcome after trauma</article-title>
                  <source>J Trauma</source>
                  <year>2007</year>
                  <volume>63</volume>
                  <issue>5</issue>
                  <fpage>1127</fpage>
                  <lpage>1131</lpage>
                  <?supplied-pmid 17993961?>
                  <pub-id pub-id-type="pmid">17993961</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>LC</given-names>
                    </name>
                    <name>
                      <surname>Raty</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Ortiz</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bailard</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Mathew</surname>
                      <given-names>SJ</given-names>
                    </name>
                  </person-group>
                  <article-title>The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries</article-title>
                  <source>CNS Neurosci Ther</source>
                  <year>2013</year>
                  <volume>19</volume>
                  <issue>6</issue>
                  <fpage>390</fpage>
                  <lpage>395</lpage>
                  <?supplied-pmid 23480625?>
                  <pub-id pub-id-type="pmid">23480625</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
